Impact and cost-effectiveness of the 6-month BPaLM regimen for rifampicin-resistant tuberculosis: a mathematical modeling analysis
View ORCID ProfileLyndon P. James, View ORCID ProfileFayette Klaassen, View ORCID ProfileSedona Sweeney, View ORCID ProfileJennifer Furin, View ORCID ProfileMolly F. Franke, View ORCID ProfileReza Yaesoubi, View ORCID ProfileDumitru Chesov, View ORCID ProfileNelly Ciobanu, View ORCID ProfileAlexandru Codreanu, View ORCID ProfileValeriu Crudu, View ORCID ProfileTed Cohen, View ORCID ProfileNicolas A. Menzies
doi: https://doi.org/10.1101/2023.07.28.23293104
